DPTX3186
Asset
Sequesters beta-catenin into inactive depot condensates, inhibiting beta-catenin and Wnt-pathway activity.
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Not known
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Advanced solid tumor
Phase 1, dewpointx.com, 10 Oct 2026
Gastric cancer
Phase 1, dewpointx.com, 10 Oct 2026
In the full profile
- Owner and partners1
- Competitors4
Every asset’s record: target, stage, trials and the evidence behind it.